High Expression of TMEM180, a Novel Tumour Marker, Is Associated with Poor Survival in Stage III Colorectal Cancer
Takuya Shiraishi(National Cancer Center Hospital East), Yasuhiro Matsumura(The Rogosin Institute), Yuji Nishizawa(National Cancer Center Hospital East), Sinji Saijou(National Cancer Research Institute), Genichiro Ishii(Juntendo University), Yuichiro Tsukada(National Cancer Center Hospital East), Koji Ikeda(National Cancer Centre Japan), Masahiro Yasunaga(Japan Clinical Cancer Research Organization), Masaaki Ito(National Cancer Centre Japan), Ryo Tsumura(National Cancer Center Hospital East), Motohiro Kojima(National Cancer Center Hospital East), Takeshi Sasaki(Sapporo Medical University)
Cited by 0
Related Papers
A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.
|PubMed|1986|6.8k
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
|Journal of Controlled Release|2000|6.5k
Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments
|Cancer Cell|2022|828